Condition
High-Risk Cancer clinical trials and research
As of November 12, 2026, Find a Trial lists 5 High-Risk Cancer clinical trials that are recruiting, at sites in 4 countries (most in China (2), United States (1), Italy (1)). By phase: Phase 3 (2). Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.
- 5Clinical trials
- 4Countries
Newest High-Risk Cancer clinical trials
| Study | Phase | Where | Status | Registered |
|---|---|---|---|---|
| Short-course radiotherapy plus intensified chemotherapy and targeted therapy with immunotherapy for high-risk rectal cancer | Phase 3 | Guangzhou, Guangdong | Recruiting | Apr 24, 2026 |
| Performance analysis of an HPV test for anal cancer screening | — | Milan | Recruiting | Mar 25, 2024 |
| Combining Toripalimab with Capecitabine for High-Risk Nasopharyngeal Carcinoma | Phase 3 | Ganzhou, Jiangxi and 2 other locations | Recruiting | Feb 26, 2024 |
| Research on lung cancer screening behaviors and outcomes in high-risk individuals in Taiwan | — | Taichung, Taiwan and 6 other locations | Recruiting | Sep 28, 2022 |
| Assessing cancer risk in individuals | — | Greenville, South Carolina | Recruiting | Jul 1, 2021 |
All recruiting trials (5)
-
Short-course radiotherapy plus intensified chemotherapy and targeted therapy with immunotherapy for high-risk rectal cancer
This trial tests whether adding targeted therapy and a PD-1 inhibitor to a short course of radiotherapy and standard chemotherapy helps high-risk pMMR/MSS rectal cancer patients, compared with the same radiotherapy and chemotherapy alone.
-
Performance analysis of an HPV test for anal cancer screening
This study is testing a new HPV test on anal samples to see if it can help high-risk people find anal cancer and precancerous conditions more easily.
-
Combining Toripalimab with Capecitabine for High-Risk Nasopharyngeal Carcinoma
This study is testing if combining toripalimab with capecitabine can help high-risk nasopharyngeal cancer patients avoid cancer coming back after their initial treatment.
-
Research on lung cancer screening behaviors and outcomes in high-risk individuals in Taiwan
This study looks at how high-risk individuals in Taiwan, like smokers or those with a family history of lung cancer, are getting screened for lung cancer using low-dose CT scans to see how effective these screenings are.
-
Assessing cancer risk in individuals
This study is testing how personal history, lifestyle, and biological samples can help identify people at higher risk of developing cancer so they can get the right care.
Related topics
Quick answers
How many High-Risk Cancer clinical trials are recruiting right now?
5, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.
Where are these trials running?
In 4 countries. The most sites are in China (2 trials), United States (1 trial), Italy (1 trial), Taiwan (1 trial). Each study page lists its sites and which ones are recruiting.
What phases are they in?
Phase 3: 2. Trials with no phase listed are usually device, behavioural or observational studies.
How do I join one?
Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.
Find the studies that fit you
A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.